ReviewKorean journal of neurotrauma2026
Diagnosis of Mild Traumatic Brain Injury: A Narrative Review of Advances in Neuroimaging and Patient-Reported Outcome Measures.
Review in Korean journal of neurotrauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mild traumatic brain injury (mTBI) is one of the most common neurological injuries, yet its diagnosis remains challenging because of heterogeneous case definitions, the limited sensitivity of conventional imaging, and the nonspecific nature of post-traumatic symptoms. Computed tomography is widely used in acute trauma care to exclude life-threatening intracranial lesions, but it is often normal in patients with mTBI, including those with persistent symptoms. Conventional magnetic resonance imaging (MRI) may improve lesion detection, although many patients still show no clear abnormalities despite ongoing clinical impairment. Recent advances in neuroimaging, including susceptibility-based imaging, diffusion MRI, magnetic resonance spectroscopy, volumetric analysis, and functional MRI, have improved understanding of subtle structural, microstructural, metabolic, and functional changes after mTBI. In parallel, patient-reported outcome measures (PROMs) have become important tools for assessing symptom burden, functional limitations, emotional distress, and health-related quality of life that may not be captured by imaging alone. In this narrative review, we summarize recent advances in neuroimaging and PROMs in the diagnostic assessment of mTBI and discuss their strengths, limitations, and complementary roles. An integrated approach combining clinical evaluation, imaging findings, and patient-reported outcomes may improve diagnostic characterization and support more individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.